Partners
Proud to Partner with:
Biose Industrie
Lead Partner
Biose Industrie is a Contract Development and Manufacturing Organization (CDMO), specialised in Live Biotherapeutic Products (LBPs) and Next Generation Probiotics (NGPs). Founded in 1951 by pharmacists and microbiologists, Biose Industrie has been manufacturing drug substance and drug products based on microorganisms for over 70 years. With 52000m² GMP Microbiome centre of excellence in France and our Tech transfer laboratory close to Boston we offer:
- Process and Analytical Development for Drug Substance and Drug Product
- Scale up for Drug Substance and Drug product
- GMP manufacturing for clinical and commercial Drug Substance and Drug Product including Placebo and full packaging and labelling
- We have experience with over 400 different strains of bacteria and 70% of them are strictly anaerobic micro-organisms.
Bac3Gel
Expertise Partner
Who We Are:
Bac3Gel is an innovation-driven company unblocking microbiota's full potential through simplified, bioinspired solutions. We offer ready-to-use in vitro models and growth enhancer beads, tailored to provide optimal conditions for microbiota to thrive. Our standard formulations cover key areas such as oral, airway, gastric, intestinal, cervicovaginal, and universal applications, advancing research in a high throughput manner, while reducing R&D time with cutting-edge, scalable technologies.
What We Do:
- Ready to use in vitro models and Growth enhancer Beads.
- Our technology is a tailorable system that provides the microbiota with the required conditions to thrive.
- Available Standard Formulations for different districts: Oral, Airway, Gastric, Intestinal, Cervicovaginal, and Universal.
Wacker Biotech
Expertise Partner
Wacker Biotech is the CDMO partner of choice for process development and contract manufacturing of biopharmaceuticals (live biotherapeutic products, proteins, vaccines, plasmid DNA and mRNA). With our proprietary LIBATEC® platform, we offer clients vast experience in process development, optimization, analytical testing and GMP manufacturing of live biotherapeutic products (LBPs). LIBATEC® provides a monoseptic environment suitable for a wide range of LBPs from diverse bacterial strains, and for both aerobic and nonaerobic fermentation regimes.
Sacco System
Innovation Partner
Sacco System is an international biotech company serving the agriculture, food, nutraceutical, and pharmaceutical industries across 110 countries. With over 150 years of experience, they offer customized probiotic solutions through proprietary strains and blends. With GMP certified facilities, and sites worldwide located, Sacco System provides support in research, development, process validation, and commercial production of probiotics, postbiotics, NEXT-Gen, and LBPs to meet consumer needs with innovative and reliable solutions in the nutraceutical and pharmaceutical sectors.
Cmbio
Exhibition Partner
Cmbio is the first-ever microbiome service and technology company with a global infrastructure of state- of-the-art multi-omics laboratories, advanced bioinformatics, applied AI and integrative systems biology expertise meeting GxP standards and enabled with a validated, highly scalable, and compatible software platform to analyze and visualize data from microbiome studies.
Transpharmation
Exhibition Partner
Transpharmation is an accredited preclinical contract research organization specializing in translational pharmacology across various therapeutic areas. We offer neuroscience expertise, utilizing behavioral and molecular assays to help clients benchmark compounds. With extensive experience in antibiotic treatments and diet manipulations, we study their effects on the microbiome. Committed to on-time data delivery and providing flexible, customized solutions, we support clients in optimizing preclinical assets for the development of life-changing medicines.
InnoGI
Event Partner
About SurroGUT™ and InnoGI Technologies
InnoGI Technologies, headquartered in Delft, Netherlands, is an innovative CRO and technology provider for the pharmaceutical and food industries. Its SurroGUT™ platform uses advanced in vitro models such as TIM, mimicking with high fidelity the complex dynamics of the human gut. TIM replicates dynamic pH profiles, peristalsis, enzyme and digestive fluid secretions to evaluate APIs, novel foods, and supplements, reducing formulation iterations and de-risking clinical trials. Backed by 25 years of research and 260+ publications, InnoGI accelerates development and decision-making worldwide.
Want to join these microbiome leaders?
